For more than two decades IBA provides innovative technologies for life science applications. The product portfolio includes tools for cell selection & expansion, protein production & assays as well as custom oligos & predefined DNA/RNA.
Automated cell selection via the Fab-TACS® technology directly from whole blood is possible using IBA’s design award winning FABian® device. Customized protocols depending on the cell type, the sample volume and the intended yield for the cell type of interest allow a convenient fully automatic cell isolation. Strep-tagged Fab fragments (Fab-Streps®) reversibly capture and release the target cells during the selection process. This delivers label-free, non-activated target cells in a standardized manner of highly reproducible quality. Isolated cells are suitable for all further immunologic or cell biologic investigations including cell based diagnostics or assays, e.g. pharmacological analysis of drug levels in the isolated cell fraction. Alternatively to FABian® we offer gravity flow columns for manual cells selection based on the same technology. For T cell stimulation, we offer completely novel reversible reagents, the Streptamers® for cell expansion, which provide unique flexibility for cell research.
The Strep-tag® technology is IBA's proprietary and versatile protein purification, detection and immobilization platform. It is one of the most widely used systems for affinity purification that provides exceptional pure proteins. Recently the third generation of the Strep-tag system was launched based on the new Strep-Tactin®XT and Twin-Strep-tag®. Strep-Tactin®XT is a further developed Strep-Tactin® with extra tight binding to Twin-Strep-tag® now enabling the usage of the Strep-tag® technology in applications where extra tight binding is a requirement. Thereby the third generation Strep-tag® technology now enters the field of assay development and screening. This opens new possibilities in the pharmaceutical and biotech sector for, e.g. screening of new diagnostic targets and the development of diagnostic assays.
Dr. Mike Rothe
Dr. Joachim Bertram
Managing Director, Chief Scientific Officer
Joachim Bertram received his Ph.D. in microbiology in the department of Prof. Gottschalk at the University of Goettingen. Then he moved to the department of hematology and oncology headed by Prof. Hiddemann where he has held a number of positions of increasing seniority in the biomedical profession. He conducted scientific and applied research on the use of antisense oligonucleotides and ribozymes in the field of proliferative diseases. In addition he focussed on mechanisms of drug resistance development and the use of nucleic acid based compounds for growth factor mimicry. In 1998, Joachim Bertram finished his "habilitation" in the medical faculty. He joined IBA GmbH in January 2000 and became CEO of IBA Biologics in 2001.
Dr. Herbert Stadler
Head of the Advisory Board
Over the last two decades, Herbert Stadler has built a track record as one of Germany's most active biotech entrepreneurs. He has founded or co founded several companies including Biometra GmbH, Ribonetics GmbH, HepaVec AG, IBA GmbH and DeveloGen AG. Herbert Stadler is a neurochemist by training. He obtained his Ph.D. at the Freie University of Berlin, obtained his postdoctoral lecture qualification ("Habilitation") at the University of Göttingen and headed the Molecular Neurobiology Group at the Max-Planck Institute of Biophysical Chemistry in Göttingen. He currently serves on the supervisory boards of DeveloGen AG and IBA GmbH.
Cell selection & expansion
Dr. Herbert Stadler
Protein Products & Assays
Dr. Christos Gouloudis
Marketing & Sales
Dr. Isabel Schuchardt
Director Product Management
General contact information
Phone +49 (0) 551 50672-0
Fax +49 (0) 551 50672-181
The Minister of Economics of Lower Saxony, Olaf Lies, granted the 6th Trade Award in the capital city Hanover. In the category small and medium-sized businesses IBA GmbH was nominated as one of the top five companies. This award appreciates the export-oriented German industry and honored innovative companies who have asserted themselves in the international export market. Dr. Joachim Bertram and Dr. Thomas Schmidt, both managing directors of IBA, received the prize at the trade fair in Hanover on 15 April 2015 and felt much honored to be under the first ones of totally 69 companies applied for this award.
More information and the complete press release of the award ceremony here: http://www.mw.niedersachsen.de/aktuelles/presseinformationen/minister-olaf-lies-verleiht-auenwirtschaftspreis--132900.html
Being the most recognized quality management standard in the world, ISO 9001:2015 is designed to help organizations to ensure that they meet the needs of customers and employees. It recognizes that the policies, practices and procedures of a company consistently result in high quality products and services which are provided to their customers.
Dr. Joachim Bertram, Managing Director at IBA, discusses receipt of the certificate: “Since 2004, IBA’s production and customer service fulfilled the high level of the ISO demands and standard procedures. However, gaining this accreditation now enables us to really demonstrate and highlight our high quality performance to our customers”.
IBA GmbH is dedicated to providing high quality tools for life science research and supports customers from early discovery to commercialization in industry and academia. The company offers solutions for the entire production chain of recombinant proteins, from oligonucleotide custom synthesis, cloning, transfection, protein expression and purification, to detection, immobilization and assays. We also deliver new tools for immunology research, including a growing line of tag-based reagents for cell isolation.
For more information please watch the Streptamer® video (in German).